Latest filing published 03 Oct 2017 for Intra-Cellular Therapies, Inc., €3.4M.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Alafi Capital Co LLC: trading record in brief
Alafi Capital Co LLC has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Intra-Cellular Therapies, Inc. and Stereotaxis, Inc. In total, 14 filings cover trades dated from 15 November 2006 to 2 October 2017.
Every open-market trade on record is a purchase: 13 purchases worth €5.6M, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant. 2017 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €63k. 4 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 3 October 2017, reports an open-market purchase of €3.4M in Intra-Cellular Therapies, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Alafi Capital Co LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 258,065 shares@ US$15.5070.3% of flowCommon StockSEC:0001209191-17-055362:0Canonical exit: 31 Dec 2017 (T+90)
- 44,174 shares@ US$16.3313.8% of flowCommon StockSEC:0001209191-16-153891:0Canonical exit: 6 Mar 2017 (T+90)
- 20,826 shares@ US$16.146.5% of flowCommon StockSEC:0001209191-16-153891:1Canonical exit: 7 Mar 2017 (T+90)
- 34,000 shares@ US$14.509.4% of flowCommon StockSEC:0001209191-16-150884:0Canonical exit: 12 Feb 2017 (T+90)
- 35,000 shares@ US$14.75Common StockSEC:0001181431-14-037473:0Canonical exit: 26 Feb 2015 (T+90)
- 1,034 shares@ US$14.25Common StockSEC:0001181431-14-037059:0Canonical exit: 17 Feb 2015 (T+90)
- 5,000 shares@ US$15.55Common StockSEC:0001181431-14-036335:0Canonical exit: 9 Feb 2015 (T+90)
- 5,000 shares@ US$15.23Common StockSEC:0001181431-14-036335:1Canonical exit: 10 Feb 2015 (T+90)
- 2,200 shares@ US$15.12Common StockSEC:0001181431-14-036335:2Canonical exit: 11 Feb 2015 (T+90)
- 76,804 shares@ US$7.81Common StockSEC:0000950138-06-000860:0
10 of 6 declarations
